Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
33595 Results Found
FDA authorizes new monkeypox point-of-care test, updates COVID-19 medical device shortages
The Food and Drug Administration Friday authorized for emergency use a molecular test to detect mpox (formerly known as monkeypox) at the point of care in lesion swab specimens from individuals whose health care provider suspects they have the virus.
Chair File: Effectively Preparing for and Responding to Public Health Emergencies
The COVID-19 pandemic, opioid crisis and mpox outbreak. Hurricanes Ian and Fiona. Severe storms, flooding, landslides and mudslides in Kentucky. Wildfires and straight-line winds in New Mexico.
CMS releases initial guidance on negotiating certain Medicare drug prices
The Centers for Medicare & Medicaid Services this week released for comment initial guidance implementing a program for Medicare to negotiate prices with drug makers for certain high-cost, single-source drug and biological products beginning in 2026 under the Inflation Reduction Act.
IDRs resume all payment determinations under No Surprises Act
The Centers for Medicare & Medicaid Services today instructed certified independent dispute resolution entities to resume making payment determinations for disputes involving items or services furnished on or after Oct. 25, 2022.
Hospitals and Health Systems Can be Leaders in Combating Public Health Misinformation
Hospitals and health systems can play an important role in ensuring patients have trustworthy, accurate and scientifically sound information to help them make the best health care decisions for themselves and their loved ones.
Survey looks at state approaches to renewing Medicaid, CHIP enrollments
The latest annual survey of state Medicaid and Children’s Health Insurance Program directors by the Kaiser Family Foundation and Georgetown University Center for Children and Families looks at state approaches to renewing Medicaid and CHIP enrollments over the past year and once the COVID-19 public health emergency’s continuous enrollment requirement ends on March 31.
15 states receive grants to plan Certified Community Behavioral Health Clinics
The Substance Abuse and Mental Health Services Administration yesterday awarded 15 states $1 million grants to plan and apply to participate in Medicaid’s Certified Community Behavioral Health Clinic demonstration.
HHS: FDA COVID-19 emergency use authorizations remain in effect
Health and Human Services Secretary Xavier Becerra this week amended the February 2020 COVID-19 emergency use authorization declaration so that the Food and Drug Administration’s emergency use authorizations for COVID-19 diagnostics, personal protective equipment, other medical devices, and drug and biological products will remain in effect until there is no longer a “significant potential” for a COVID-19 public health emergency or the authorized devices or products have been approved.
UPDATE: CMS pledges to ‘make whole’ providers impacted by Medicare Part B drug coinsurance reductions
The Centers for Medicare & Medicaid Services will make whole health care providers impacted by lowered coinsurance on 27 Medicare Part B prescription drugs. The reduced coinsurance rates, which are required by the Inflation Reduction Act, take effect April 1 and will remain in effect through June 30.
CMS to Reduce Medicare Coinsurance for 27 Part B Drugs, Starting April 1
The Centers for Medicare and Medicaid Services (CMS) March 15 announced 27 prescription drugs for which it will lower Part B beneficiary coinsurance, beginning April 1 through June 30, 2023, as required by the Inflation Reduction Act (IRA).